Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tomotherapy for Refractory Brain Metastases: a Single Arm, Single Center Phase II Trial

NCT03027544 is registered in ClinicalTrials.gov with Chinese Academy of Medical Sciences as lead sponsor.

NCT NCT03027544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03027544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tomotherapy for Refractory Brain Metastases: a Single Arm, Single Center Phase II Trial
Lead sponsor
Chinese Academy of Medical Sciences
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2014
Completion date
September 1, 2018
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases